Fig. 3From: Identify glioma recurrence and treatment effects with triple-tracer PET/CTA representative patient with glioma TuR. Contrast MR image (a) reveals an enhanced lesion with obviously increased uptake of 18F-FDOPA (b), slightly increased uptake of 13N-NH3 (c), and decreased uptake of 18F-FDG (d). Two months later, contrast MR showed that the lesions continued to increase (e), and the patient died 8Â months laterBack to article page